Changchun Bcht Biotechnology Co.
Clinical trials sponsored by Changchun Bcht Biotechnology Co., explained in plain language.
-
New combo vaccine for whooping cough, diphtheria, and tetanus enters first human tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage study tests the safety and immune response of different doses of a combined vaccine against whooping cough, diphtheria, and tetanus in 96 people aged 10 and older. Participants will receive either the vaccine or a placebo, and researchers will monitor for side ef…
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 02:42 UTC
-
New flu vaccine candidate enters first human tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial tests a new flu vaccine with an added ingredient (adjuvant) to boost immune response. About 160 adults aged 18 and older will receive either the test vaccine, a standard flu vaccine, or a placebo. Researchers will monitor side effects and measure antibody l…
Phase: PHASE1 • Sponsor: Changchun BCHT Biotechnology Co. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 02:40 UTC